Ben Steinberg
Partner
Ben Steinberg is an antitrust litigator with over a decade of experience prosecuting anticompetitive conduct on behalf of consumers and businesses nationwide. With a firm commitment to fair competition and a command of innovative litigation strategies, Ben has helped lead several groundbreaking lawsuits across the country, recovering hundreds of millions of dollars for his clients. Ben repeatedly has been recognized as one of the top antitrust attorneys in the country under the age of 40.
Ben’s practice spans the full spectrum of antitrust matters, from class actions and corporate disputes through trial and appeal. Chambers USA calls Ben “an up-and-coming attorney who advises clients on sophisticated antitrust litigation.” An emerging voice on competition issues, Ben is regularly published in the national press and is a leading advocate on antitrust policy, particularly with respect to climate change, conspiracy law and class-action procedure.
Ben pioneered the first-ever comprehensive database of U.S. antitrust class-certification decisions, which will soon be available to the public.
Outside his antitrust work, Ben maintains a diverse litigation practice encompassing data privacy disputes, fraud matters and internal investigations. Ben is committed to pro bono work and has helped secure asylum for several Afghan refugees.
- In re Disposable Contact Lens Antitrust Litigation. As co-lead counsel, Ben secured settlements in excess of $118 million for U.S. contact lens purchasers challenging a series of “minimum pricing” policies imposed by the four dominant manufacturers and the largest nationwide distributor of contact lenses.*
- BCBSM, Inc. v. Vyera Pharmaceuticals, LLC et al. Ben secured a settlement valued at $28 million on behalf of a class of third-party payers who alleged that Martin Shkreli and his former companies illegally monopolized the market for the life-saving drug Daraprim.*
- In re Fragrance End-User Plaintiff Antitrust Litigation. Ben serves as co-lead counsel on behalf of a class of consumers and businesses who purchased consumer products or household goods, not for resale, which contained fragrance products that were manufactured by the defendants.
- In re Wells Fargo Collateral Protection Insurance Litigation. As co-lead counsel, Ben secured settlements of more than $400 million for auto loan customers who alleged Wells Fargo and National General Insurance Company illegally charged them for duplicative and unnecessary auto insurance.*
*Result obtained prior to joining SCL
Bar Admissions
New York
Eastern District of New York
Southern District of New York
Ninth Circuit Court of Appeals
Education
University of Minnesota Law School, J.D., magna cum laude (2013)
University of Wisconsin–Madison, B.A. (2010)
Chambers USA, Up and Coming: Antitrust — Mainly Plaintiff (2024)
Benchmark Litigation, 40 & Under List (2024)
Law360, Top Attorneys Under 40 (2023)
The National Law Journal, Rising Star of the Plaintiffs Bar (2022)
American Antitrust Institute, Outstanding Antitrust Litigation Achievement by a Young Lawyer (2020)
Concurrences, Nominee for Antitrust Writing Awards (2019, 2021)
Media Mentions
“Rising star: Ben Steinberg,” Law 360 (July 5, 2023)
“Law360 names 2023’s top attorneys under 40,” Law 360 (June 19, 2023)
“Golf’s antitrust problem just got bigger,” The New York Times (July 5, 2023)
“The 2022 rising stars of the plaintiffs bar,” The National Law Journal (Aug. 24, 2022)
“Customers win $31m fees in contact lens price-fixing MDL,” Law360 (Oct. 12, 2022)
“Martin Shkreli reaches settlement to pay $28 million to resolve Blue Cross and Blue Shield litigation,” Law & Crime (Jan. 31, 2022)
“Shkreli’s former drug company to settle antitrust class action,” Reuters (Jan. 28, 2022)
“Shkreli, Vyera to settle out of BCBS antitrust class action,” Law360 (Dec. 10, 2021)
“Blue Cross unit wants to lead if Shkreli faces new suits,” Law360 (May 6, 2021)
“‘Pharma Bro’ Shkreli hit with 1st private antitrust suit,” Law360 (March 4, 2021)
“‘Pharma Bro’ Martin Shkreli, Vyera targeted in private class action stemming from drug price hike,” New York Law Journal (March 4, 2021)
“AAI congratulates honorees at the 2020 Antitrust Enforcement Awards program,” American Antitrust Institute (Nov. 12, 2020)
“Can COVID-19 help cut insulin prices permanently?,” A Sweet Life (May 8, 2020)
“Antitrust cases to watch in 2019,” Law360 (Jan. 1, 2019)
“Consumer class certified in contact lens price-fix row,” Law 360 (Dec. 5, 2018)
“High court hears dental supplies antitrust suit’s arbitration fight,” Bloomberg Law (Oct. 29, 2018)
Speeches & Events
“Previewing the antitrust class certification database,” New York State Bar Association (Dec. 15, 2021)
“What role will consumer litigation play in the antitrust fight over tech platforms?,” New York State Bar Association (Jan. 30, 2020)
“Litigation financing in antitrust: Pragmatic and ethical considerations in an emerging market,” New York State Bar Association (Nov. 7, 2019)
“Cartel damages claims: Economic approaches to estimating overcharges,” New York State Bar Association (Sept. 12, 2017)
New York State Bar Association Antitrust Law Section
(Executive Board Member, 2021-2024)
Committee to Support the Antitrust Laws, Climate and Antitrust Committee
(Vice Chair, 2023-2024)
“U.S. antitrust regulators should foster climate collaboration,” Law360 (April 13, 2021)
“States can use the coronavirus response to go after insulin price gougers,” Slate (April 9, 2020)
“Immunizing banks from Libor liability could hurt consumers,” Law 360 (July 23, 2020)
“Unintended consequences: How a DOJ antitrust investigation could exacerbate global warming,” The National Law Journal (Dec. 17, 2019)
“Antitrust law could help Mueller prove that Trump officials conspired with Russia,” Slate (Feb. 21, 2019)
“Defendant class actions: The solution to suing hundreds of defendants,” Bloomberg Law (Nov. 8, 2018)
“Revisiting the applicability and scope of Daubert at class certification three years after Comcast v. Behrend,” Antitrust Health Care Chronicle (Feb. 2016)
